Cell banking outsourcing refers to the practice of contracting external organizations to establish, maintain, and manage repositories of cell lines crucial for various applications in biotechnology and pharmaceutical industries, such as drug discovery and biomanufacturing. It ensures that cells are handled, stored, and maintained under standardized conditions, ensuring consistency and reliability.
Sizing and Forecast
The cell banking outsourcing market size has grown rapidly in recent years. It will grow from $9.76 billion in 2023 to $11.19 billion in 2024 at a compound annual growth rate (CAGR) of 14.7%. The growth in the historic period can be attributed to the rise in the prevalence of chronic diseases, the increased number of government initiatives, regulatory support and guidelines, and the increase in the establishment of banking services.
The cell banking outsourcing market size is expected to see rapid growth in the next few years. It will grow to $19.51 billion in 2028 at a compound annual growth rate (CAGR) of 14.9%. The growth in the forecast period can be attributed to rising adoption of cellular products, growing demand for monoclonal antibodies, increasing adoption of stem cell therapies, rising geriatric population, and growing dependency on cell-based therapies. Major trends in the forecast period include product innovations, technological advancements, investments in research and development, and the collaboration between biotech companies and specialized cell banking services.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/cell-banking-outsourcing-global-market-report
Segmentation & Regional Insights
The cell banking outsourcing market covered in this report is segmented –
1) By Type: Master Cell Banking, Working Cell Banking, Viral Cell Banking
2) By Cell Type: Stem Cell Banking, Non-Stem Cell Banking
3) By Phase: Bank Storage, Bank Characterization And Testing, Bank Preparation
North America was the largest region in the cell banking outsourcing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell banking outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15754&type=smp
Major Driver Impacting Market Growth
The rise in the burden of chronic diseases is expected to propel the growth of the cell banking outsourcing market going forward. Chronic diseases are long-lasting conditions that typically develop gradually and persist over an extended period. The rising prevalence of chronic diseases can be attributed to a combination of various factors, including lifestyle changes, aging populations, and genetic predispositions. Cell banking outsourcing plays a valuable role in advancing research and development efforts aimed at addressing chronic diseases by providing access to expertise, resources, and infrastructure that may not be available in-house. For instance, in July 2023, according to the Department of the Treasury, an Australia-based national treasury and financial department, in 2020–21, nearly half of Australians of all ages (46.6%) had one or more chronic diseases, and almost one in five (18.6%) had two or more chronic conditions. Therefore, the rise in the burden of chronic diseases is driving the growth of the cell banking outsourcing market.
Key Industry Players
Major companies operating in the cell banking outsourcing market are Labcorp Drug Development, SGS Life Sciences, Lonza Group Ltd., WuXi AppTec, Charles River Laboratories, Sigma-Aldrich Co. Ltd., Covance Inc., Global Stem Inc., LifeCell, Cryoviva India, Sartorius AG, Bio Reliance, CordLife, Reliance Life Sciences, Cryo-Cell International Inc., Toxikon Corp., Cleancells, Clean Biologics, Texcell, PX’Therapeutics SA, Goodwin Biotechnology Inc., Transcell Biolife Pvt Ltd, Perfectus Biomed Limited, BioStorage Technologies Inc.
The cell banking outsourcing market report table of contents includes:
1. Executive Summary
2. Cell Banking Outsourcing Market Characteristics
3. Cell Banking Outsourcing Market Trends And Strategies
4. Cell Banking Outsourcing Market – Macro Economic Scenario
5. Global Cell Banking Outsourcing Market Size and Growth
…………………………
32. Global Cell Banking Outsourcing Market Competitive Benchmarking
33. Global Cell Banking Outsourcing Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Cell Banking Outsourcing Market
35. Cell Banking Outsourcing Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
